• The global Metal Non-covered Biliary Stent Market was valued at approximately USD 387.5 million in 2024 and is projected to reach around USD 552.4 million by 2030, growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period.

• North America held the largest market share in 2024, supported by advanced healthcare infrastructure, high procedural volumes for biliary obstructions, and the strong presence of leading medical device manufacturers.

• The malignant biliary obstruction segment dominated the market, valued at approximately USD 250 million in 2024, owing to the increasing incidence of pancreatic and bile duct cancers requiring palliative stenting procedures.

• Technological advancements such as laser-cut self-expanding stents and improvements in biocompatibility and radial strength are enhancing clinical outcomes and procedural efficiency.

• The Asia-Pacific region is expected to witness the fastest growth through 2030, driven by a growing patient population with hepatobiliary disorders, rising healthcare expenditures, and expanding adoption of minimally invasive treatments.

• Key market players include Boston Scientific Corporation, Cook Medical, Olympus Corporation, Taewoong Medical Co. Ltd., and Micro-Tech (Nanjing) Co. Ltd., focusing on new product development, regulatory approvals, and global distribution partnerships.

• Challenges such as risk of stent occlusion, procedural complications, and limited awareness in emerging markets may restrain market growth during the forecast period.

In this report, the Metal Non-covered Biliary Stent Market has been segmented by Type, Application, End User, and Geography.

Metal Non-covered Biliary Stent Market Segmentation by Type

The Metal Non-covered Biliary Stent Market by type is categorized into Absorbable and Non-Absorbable stents. These segments differ in terms of material composition, functional longevity, and patient recovery outcomes. The growing adoption of biodegradable stents reflects the market’s focus on reducing post-procedural complications and improving patient comfort. Meanwhile, non-absorbable stents remain widely used due to their mechanical stability and long-term patency in complex biliary conditions.

Absorbable

Absorbable stents are gaining traction owing to their ability to dissolve naturally in the body, eliminating the need for secondary removal procedures. They are primarily used in cases where temporary biliary drainage is required. Ongoing advancements in biodegradable polymers are improving performance consistency and reducing the risk of inflammatory responses.

Non-Absorbable

Non-Absorbable stents remain the dominant type due to their superior durability and structural strength. These stents are preferred for chronic cases, particularly in malignant obstructions where long-term support is essential. Manufacturers are investing in nickel-titanium alloys (Nitinol) and innovative stent designs that enhance flexibility and reduce migration risks.

Metal Non-covered Biliary Stent Market Segmentation by Application

The market by application includes Malignant Obstruction, Biliary Leaks, Benign Biliary Strictures, and Others. The growing incidence of biliary cancers and gallbladder diseases is driving demand across these applications. Technological innovations in endoscopic stenting procedures and improvements in stent materials are enhancing therapeutic outcomes and expanding clinical adoption.

Malignant Obstruction

Malignant Obstruction represents the largest application segment, driven by the rising prevalence of cholangiocarcinoma and pancreatic cancer. Metal non-covered stents offer effective palliative care by restoring bile flow and improving patient quality of life. The segment is also benefiting from advancements in self-expanding stent technology that facilitate minimally invasive treatments.

Biliary Leaks

Biliary Leaks applications are witnessing moderate growth, supported by the increasing use of temporary stents to promote healing and control bile flow. Hospitals are increasingly favoring metal stents due to their superior drainage efficiency and structural reliability compared to plastic alternatives.

Benign Biliary Strictures

Benign Biliary Strictures are treated using metal stents to alleviate obstruction caused by postoperative or inflammatory conditions. The segment is expanding due to improvements in stent removability and the introduction of biocompatible materials designed to reduce tissue irritation. Long-term clinical success rates have enhanced confidence in using non-covered stents for benign cases.

Others

The Others category includes rare and complex conditions requiring customized stenting approaches. This segment benefits from growing research collaborations between medical device manufacturers and healthcare institutions to develop specialized stent configurations for unique biliary challenges.

Metal Non-covered Biliary Stent Market Segmentation by End User

The Metal Non-covered Biliary Stent Market by end user includes Hospitals, Clinics, and Ambulatory Surgical Centers. The segmentation reflects the diversification of care delivery settings driven by the growing preference for minimally invasive endoscopic procedures. The rising availability of advanced diagnostic and interventional technologies across healthcare facilities further fuels market adoption.

Hospitals

Hospitals represent the leading end-user segment owing to their comprehensive treatment infrastructure and high patient inflow for biliary procedures. The presence of specialized gastroenterology and oncology departments supports the demand for advanced stent systems. Continuous staff training and multidisciplinary approaches enhance procedural outcomes and patient safety.

Clinics

Clinics are emerging as significant contributors due to their growing capability to perform outpatient stent placements. The expansion of private healthcare networks and accessibility to compact endoscopic systems are facilitating market growth in this segment. Clinics are increasingly focusing on cost-effective treatment solutions to attract patients seeking minimally invasive options.

Ambulatory Surgical Centers

Ambulatory Surgical Centers (ASCs) are gaining momentum as preferred facilities for day-care procedures. Their ability to provide rapid recovery environments and reduced hospital stays makes them ideal for routine biliary stent placements. The growth of ASCs aligns with the global trend toward decentralized healthcare delivery and value-based care models.

Metal Non-covered Biliary Stent Market Segmentation by Geography

In this report, the Metal Non-covered Biliary Stent Market has been segmented by Geography into five regions: North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

North America

North America dominates the global market, driven by a well-established healthcare infrastructure and early adoption of minimally invasive endoscopic procedures. The U.S. leads in terms of technological innovations, supported by major manufacturers and a robust reimbursement framework. The region’s high prevalence of gastrointestinal cancers continues to support steady market expansion.

Europe

Europe maintains a significant share, supported by strong clinical research initiatives and advanced hospital systems. Countries such as Germany, France, and the UK are investing in endoscopic imaging and metal stent technologies to enhance procedural outcomes. Stringent regulatory frameworks are promoting the use of high-quality, safe medical devices across the region.

Asia Pacific

Asia Pacific is expected to record the fastest growth rate due to increasing healthcare investments and the growing burden of biliary and pancreatic disorders. Rising awareness of minimally invasive treatments and expanding access to specialized gastroenterology services are key growth drivers. Local manufacturing initiatives and cost-effective production in China and India are also supporting market penetration.

Middle East & Africa

The Middle East & Africa region is witnessing gradual growth driven by improving medical infrastructure and the introduction of advanced diagnostic centers. Increasing government initiatives to modernize healthcare facilities and train medical professionals in endoscopic procedures are enhancing market adoption.

Latin America

Latin America shows a promising outlook with growing investments in healthcare modernization and expanding access to endoscopic stenting devices. Countries such as Brazil and Mexico are key markets where rising cancer incidence and public healthcare expansion are driving the demand for metal non-covered biliary stents.

This report provides an in depth analysis of various factors that impact the dynamics of Metal Non-Covered Biliary Stent Market. These factors include; Market Drivers, Restraints, and Opportunities.

Drivers, Restraints and Opportunity Analysis

Drivers:

• Increasing prevalence of biliary disorders
• Surge in minimally invasive procedures
• Favorable reimbursement policies

• Demand for long-term palliative care solutions - The increasing demand for long-term palliative care solutions plays a pivotal role in the growth of the Metal Non-Covered Biliary Stent Market. With a rise in chronic biliary conditions like biliary obstruction, there is a growing need for effective, long-lasting treatments. Metal non-covered biliary stents are frequently used in these cases, offering a practical solution for patients who are not eligible for surgery. These stents help maintain bile flow, offering significant relief to individuals suffering from bile duct blockages, especially in the context of long-term palliative care.

  In particular, metal non-covered biliary stents are essential for patients with advanced cancers, such as pancreatic and liver cancers, where surgical options are limited. These patients often experience obstructed bile ducts due to the spread of cancer, and stents are crucial in managing symptoms like jaundice. By ensuring the continued flow of bile, these stents improve the patient's overall comfort, allowing them to better manage their condition while undergoing other treatments, including chemotherapy or radiation therapy.

  As the healthcare industry increasingly focuses on enhancing patient comfort and providing quality palliative care, the demand for non-covered biliary stents has risen. Unlike covered stents, which are primarily designed to prevent stent occlusion, non-covered stents are ideal for long-term palliative care. Their effectiveness in managing chronic conditions with minimal need for replacements makes them a preferred choice for healthcare providers and patients looking for durable and non-invasive treatment options. Technological advancements in the design of these stents have also contributed to their growing popularity. Modern metal non-covered biliary stents are made from more durable materials, offering longer-lasting performance and reducing the need for frequent replacements. As the aging population and prevalence of chronic biliary diseases continue to rise, the demand for these stents is expected to increase, making them an integral component of long-term palliative care solutions worldwide.

Restraints:

• Stringent regulatory approval
• Stent-related complications risk
• Limited skilled healthcare workforce
• Durability and efficacy concerns

• Ethical dilemmas in end-of-life care - Ethical dilemmas in end-of-life care serve as a significant restraint on the Metal Non-Covered Biliary Stent Market. These stents are frequently used in palliative care for patients with advanced diseases, such as cancer, where difficult decisions arise regarding treatment choices. Healthcare providers must balance the benefits of these stents with the patient’s overall prognosis and their wishes for end-of-life care. In some instances, the use of a stent might prolong suffering or go against the patient's preference for a more natural, comfortable death, creating moral complexities for the medical team.

  The decision to implant a metal non-covered biliary stent can also lead to ethical questions about the value of prolonging life versus the potential for unnecessary interventions. For patients in terminal stages of illness, the stent may offer temporary relief from symptoms like jaundice, but it may not significantly extend survival or improve quality of life. This brings up concerns about the responsible use of healthcare resources, especially when patients may prioritize comfort over invasive treatments. These moral quandaries can cause disagreements among families and healthcare providers, especially if the patient’s wishes are unclear or not well understood.

  In palliative care settings, obtaining informed consent for such procedures can be ethically challenging. Many patients with severe illnesses have impaired cognitive functions, making it difficult to ensure they fully understand the implications of using a stent. This complicates the consent process and often leaves families in the position of making critical decisions for their loved ones. These emotional and ethical challenges are amplified when there is a lack of clear medical guidance or when the family is unsure of the best course of action.

Opportunities:

• Adoption of value-based healthcare
• Integration of digital health solutions
• Tailored product offerings
• Physician training investments

• Patient-centric services development - The development of patient-centric services offers a significant opportunity for the Metal Non-Covered Biliary Stent Market. As the healthcare industry continues to prioritize personalized care, there is an increasing demand for solutions that cater specifically to individual patient needs and preferences. Metal non-covered biliary stents, which are often used in palliative care, present an opportunity to enhance the overall healthcare experience by focusing on tailored treatment plans. This patient-centered approach not only involves the medical device itself but also encompasses the entire care journey, from diagnosis and treatment to long-term management, ultimately leading to improved patient satisfaction and outcomes.

  The shift toward patient-centric care emphasizes reducing discomfort, shortening hospital stays, and improving the quality of life for patients with chronic conditions. Metal non-covered biliary stents are ideal in this context, as they provide a long-term solution for patients suffering from bile duct obstructions, especially those with advanced cancers. These stents allow for more effective disease management at home, reducing the need for frequent hospital visits, which supports a more patient-focused approach. This trend aligns with the growing demand for treatments that prioritize comfort and convenience, making these stents a valuable option in modern healthcare.

Metal Non-covered Biliary Stent Market has witnessed significant growth driven by strategic partnerships, mergers, and collaborations among leading medical device manufacturers. Continuous innovation in stent design, material composition, and biocompatibility has enhanced patient outcomes. Market expansion is evident with key segments achieving over 45% adoption in hepatobiliary interventions, supporting a robust future outlook.

Market Structure and Concentration
The market exhibits moderate concentration with top players controlling around 60% of total sales. Competitive strategies focus on product differentiation, regulatory compliance, and clinical reliability. Smaller firms leverage niche innovation to target specialized patient segments. Strategic mergers and collaborations continue to shape market hierarchy, sustaining long-term growth.

Brand and Channel Strategies
Leading brands implement multi-channel strategies including direct hospital supply, distributor networks, and specialized clinics. Collaborative partnerships with gastroenterologists and surgical centers enhance visibility. Product innovation in stent flexibility, radial force, and anti-migration features has increased adoption by over 35%, driving market expansion and strengthening brand positioning across regions.

Innovation Drivers and Technological Advancements
Technological advancements in stent alloys, surface coatings, and delivery systems drive continuous innovation. Collaborative R&D initiatives improve procedural success, safety, and patient outcomes. Adoption of advanced manufacturing and coating techniques has enhanced stent performance by over 30%, reinforcing market growth and supporting ongoing future outlook developments.

Regional Momentum and Expansion
The Metal Non-covered Biliary Stent market is witnessing strong regional expansion across North America, Europe, and Asia-Pacific, with certain regions contributing over 40% of total sales. Strategic distribution partnerships and localized clinical collaborations enhance adoption. Rising hepatobiliary disease prevalence drives market growth and shapes the future outlook.

Future Outlook
Market projections indicate sustained growth driven by continuous innovation, strategic collaborations, and mergers among key players. Expanding regional presence and advanced technological advancements are expected to boost adoption. Leading segments are projected to maintain over 45% market share, reflecting a robust future outlook for metal non-covered biliary stents.

Key players in Metal Non-Covered Biliary Stent Market include:

• Boston Scientific Corporation
• Cook Medical LLC
• Taewoong Medical Co., Ltd.
• Merit Medical Systems, Inc.
• C.R. Bard (now part of Becton, Dickinson & Company)
• Teleflex Incorporated
• PNN Medical A/S
• Carlton/CONMED Corporation
• Olympus Corporation
• AMG International
• Becton, Dickinson & Company (BD Interventional)
• Abbott Laboratories
• Biotronik SE & Co. KG
• Micro-Tech (Nanjing) Co., Ltd.
• EndoChoice Holdings, Inc.

In this report, the profile of each market player provides following information:

• Market Share Analysis
• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis